Tamir Biotechnology, Inc.
2 clinical trials · Sponsor
◉ Watch Tamir Biotechnology, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) (NCT02535104) | Tamir Biotechnology, Inc. | 2016-02-01 |
| A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer (NCT01184287) | Tamir Biotechnology, Inc. |
Track Tamir Biotechnology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.